State of Play of Managing Heart Failure with SGLT2i – does EF matter?. Sophia Zoungas • John Amerena • Athula Karunanayaka • Ingrid Hopper THURSDAY, 6th OCTOBER 2022. WATCH HERE Recent livestream events you may have missed Severe mental health and diabetes, the role of a multi-disciplinary team > Living Evidence Guidelines > Lessons from current guidelines and ASN > Improving diabetes management > Why SGLT2 inhibitors should be used in heart failure > 100 years of Insulin > Why time in range matters > To assist us in our on going commitment to providing timely, relevant content please let us know your topic of interest Your Email Topics of interest (select more than one) Adolescent prediabetes CKD & New Medications Consulting Skills Continued Glucose Monitoring Diabetes and Mental Health Diabetic Foot Disease Diabetic Retinopathy DKA with SGLT2i Early use of GLP1 Erectile Defunction Flash Glucose Monitoring Gestational Diabetes Initiating Insulin Insulin and GLP1 Insulin Pumps Living Guidelines Non-Glycaemic Management of CVD Obesity Research Update Technology Other Please enter any unlisted topics of interest here
